Order Article Reprints

Tabata T, Petitt M, Li J, Chi X, Chen W, Yurgelonis I, Wellnitz S, Bredl S, Vicente T, Yang X, et al. Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas. Vaccines. 2022; 10(7):1074. https://doi.org/10.3390/vaccines10071074

Tabata, Takako, Matthew Petitt, Julia Li, Xiaoyuan Chi, Wei Chen, Irina Yurgelonis, Sabine Wellnitz, Simon Bredl, Tiago Vicente, Xinzhen Yang, and et al. 2022. "Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas" Vaccines 10, no. 7: 1074. https://doi.org/10.3390/vaccines10071074

Tabata, T., Petitt, M., Li, J., Chi, X., Chen, W., Yurgelonis, I., Wellnitz, S., Bredl, S., Vicente, T., Yang, X., Dormitzer, P. R., & Pereira, L. (2022). Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas. Vaccines, 10(7), 1074. https://doi.org/10.3390/vaccines10071074